Investor Presentation Full Year 2017

Investor Presentation Full year 2017 The GLP-1 segment accounts for around 1% of the total diabetes care market value in Region China Slide 72 GLP-1 value in bDKK China GLP-1 market VictozaⓇ exenatide Share of total diabetes care GLP-1 value VictozaⓇ value market share in China VictozaⓇ exenatide market share market 100% 0.20 2.0% CAGR value¹: 28.3% 0.15 80% 1.5% 69% 60% 0.10 - 1.0% 40% -31% 0.05 + 0.5% 20% 0.00 Nov 2012 0.0% 0% Nov 2017 Nov 2012 Nov 2017 1 CAGR for 5-year period. Source: IQVIA (formerly IMS) monthly MAT Nov, 2017 value figures (DKK) changing diabetes® Source: IQVIA (formerly IMS) monthly MAT Nov, 2017 value figures (DKK) novo nordisk

View entire presentation